Investors

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

SEC Filing Details

Document Details

Form
Filing Date
Jan 20, 2023
Document Date
Jan 9, 2023
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
Homology Medicines, Inc.
Issuer
Homology Medicines, Inc.
Filer
Seymour Albert